Mabcampath and cytomegalovirus infection Patient Reports February 11, 2012

Mabcampath Side Effects Report #5777966-0
Mabcampath side effect was reported by a Pharmacist from NETHERLANDS on June 09, 2008. Male patient, 62 years of age, weighting 187.4 lb, was diagnosed with t-cell depletion, bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus infection, multi-organ failure, pneumonia cytomegaloviral, post transplant lymphoproliferative disorder. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, BUSULPHAN. Patient died on 03/08/2008.

Mabcampath Side Effects Report #5779911-0
Mabcampath side effect was reported by a Pharmacist from NETHERLANDS on June 09, 2008. Male patient, 62 years of age, weighting 187.4 lb, was diagnosed with t-cell depletion, bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus infection, multi-organ failure, pneumonia cytomegaloviral, post transplant lymphoproliferative disorder. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, BUSULPHAN. Patient died on 03/08/2008.

Mabcampath Side Effects Report #5940185-9
Mabcampath side effect was reported by a Pharmacist from UNITED STATES on June 09, 2008. Male patient, 62 years of age, weighting 187.4 lb, was diagnosed with t-cell depletion, bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, multi-organ failure, pneumonia cytomegaloviral. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, BUSULPHAN. Patient died on 03/08/2008.

Mabcampath Side Effects Report #6099472-9
Mabcampath side effect was reported by a Physician from AUSTRIA on Feb 17, 2009. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chronic lymphocytic leukaemia, cytomegalovirus infection , pancytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 08/20/2008.


Mabcampath Side Effects Report #5925118-3
Mabcampath side effect was reported by a Physician from FRANCE on Oct 15, 2008. Male patient, 63 years of age, weighting 145.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: acute hepatic failure, cardiac failure congestive, cd4 lymphocytes decreased, chronic lymphocytic leukaemia transformation, cytomegalovirus infection , leukopenia, lymphopenia, neutropenia, renal failure. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 09/11/2008.

Mabcampath Side Effects Report #5822083-4
Mabcampath side effect was reported by a Pharmacist from UNITED STATES on June 09, 2008. Female patient, 47 years of age, weighting 114.6 lb, was diagnosed with bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, multi-organ failure. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, BUSULFAN. Patient died on 05/25/2007.

Mabcampath Side Effects Report #6129984-0
Mabcampath side effect was reported by a Physician from FRANCE on Mar 20, 2009. Male patient, 63 years of age, weighting 145.5 lb, was diagnosed with b-cell small lymphocytic lymphoma recurrent and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: acute hepatic failure, cardiac failure congestive, cd4 lymphocytes decreased, chronic lymphocytic leukaemia transformation, cytomegalovirus infection , leukopenia, lymphopenia, metabolic acidosis, neutropenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 09/11/2008.

Mabcampath Side Effects Report #5759410-2
Mabcampath side effect was reported by a Physician from GERMANY on Feb 27, 2008. Female patient, 62 years of age, weighting 152.1 lb, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, aphthous stomatitis, cholestasis, cytomegalovirus hepatitis, cytomegalovirus infection , immunodeficiency, leukopenia, oedema peripheral. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5759822-7
Mabcampath side effect was reported by a Physician from GERMANY on Feb 27, 2008. Female patient, 62 years of age, weighting 152.1 lb, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, aphthous stomatitis, cholestasis, cytomegalovirus hepatitis, cytomegalovirus infection , immunodeficiency, leukopenia, oedema peripheral. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient recovered.


Mabcampath Side Effects Report #5916033-X
Mabcampath side effect was reported by a Physician from SWITZERLAND on Oct 08, 2008. Female patient, 60 years of age, weighting 127.9 lb, was diagnosed with b-cell lymphoma stage iv and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , nasal necrosis, nasal septum perforation. Mabcampath dosage: unknown. During the same period patient was treated with BACTRIM DS, MARCUMAR, VALTREX. Patient recovered.

Mabcampath Side Effects Report #5925115-8
Mabcampath side effect was reported by a Physician from SWITZERLAND on Oct 14, 2008. Female patient, 60 years of age, weighting 127.9 lb, was diagnosed with b-cell lymphoma stage iv and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , nasal necrosis, nasal septum perforation. Mabcampath dosage: unknown. During the same period patient was treated with BACTRIM DS, MARCUMAR, VALTREX. Patient recovered.

Mabcampath Side Effects Report #5776416-8
Mabcampath side effect was reported by a Physician from GERMANY on May 19, 2008. Female patient, 70 years of age, weighting 130.1 lb, was diagnosed with adult t-cell lymphoma/leukaemia, antiviral prophylaxis, antibiotic prophylaxis, antifungal prophylaxis, hypertension and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cough, cytomegalovirus infection , pyrexia. Mabcampath dosage: unknown. During the same period patient was treated with ACIC, COTRIM, DIFLUCAN, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.